2019
| Effluent from drug manufactures contains extremely high levels of pharmaceuticals Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens Occurrence of High Levels of Fluoroquinolones in Aquatic Environment due to Effluent Discharges from Bulk Drug Manufacturers | 20.8.2019 (Aurélien Emmanuel Martinez) Larsson et al., Gothwal et al, Lübbert et al: Effluent from drug manufactures contains extremely high levels of pharmaceuticals Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens Occurrence of High Levels of Fluoroquinolones in Aquatic Environment due to Effluent Discharges from Bulk Drug Manufacturers Journal of Hazardous Materials, Infection, Journal of Hazardous, Toxic, and Radioactive Waste verschiedene verschiedene 2007, 2016, 2019 |
| Treatment Duration and Associated Outcomes for Skin and Soft Tissue Infections in Patients With Obesity or Heart Failure | 05.08.2019 (Dr. med. Lucas Dratz) Claudia Ihm et al.: Treatment Duration and Associated Outcomes for Skin and Soft Tissue Infections in Patients With Obesity or Heart Failure Open Forum Infectious Diseases 6, Issue 6 ofz217 2019 |
| Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana | 29.07.19 (Elisabeth Wehrle) Zash R. et al.: Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana NEJM DOI: 10.1056/NEJMoa1905230 1-14 2019 |
| Successful 6 week antibiotic Treatment for Early Surgical-site Infections in Spinal Surgery | 22.07.19 (Sandra Zingg) Fernandez-Gerlinger, et al.: Successful 6 week antibiotic Treatment for Early Surgical-site Infections in Spinal Surgery CID 2019:68(11) 1856-61 2019 |
| Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis | 15.07.2019 (Ragozzino Silvio) Wilson et al.: Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis N Engl J Med 380 2327-40 2019 |
| Fluorquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients | 08.07.2019 (Sabine Kuster) Hakki M et al.: Fluorquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients CID Volume 68-12 2045-2052 2019 |
| The Differences in Antibiotic Decision-making Between Acute Surgical and Acute Medical Teams: An Ethnographic Study of Culture and Team Dynamics | 01.07.2019 (Sarah Dräger) E. Charani et al.: The Differences in Antibiotic Decision-making Between Acute Surgical and Acute Medical Teams: An Ethnographic Study of Culture and Team Dynamics CID 69 12-20 2019 |
| Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial | 24.06.2019 (Mihaela Sava) Chen M et al.: Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial Lancet Infect Dis 2019 published online June 10 2019 |
| Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing | 03.06.2019 (Jacopo Nicoletti) Bellew S. et al.: Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing Clin. Infect. Dis. 68 2026-2033 |
| Antibacterial Envelope to Prevent Cardiac Implantable Device Infection | 27.05.2019 (Brian Duggan) Tarakji KG et al.: Antibacterial Envelope to Prevent Cardiac Implantable Device Infection N Engl J Med. 380 1895-1905 |
| Should Acute Q-Fever Patients be Screened for Valvulopathy to Prevent Endocarditis? |
|
| Decontamination Strategies and Bloodstream Infections with Antibiotic-Resistant Microorganisms in Ventilated Patients - A Randomized Clinical Trial | 13.05.2019 (Ana Durovic) Bastian H. Wittekamp et al.: Decontamination Strategies and Bloodstream Infections with Antibiotic-Resistant Microorganisms in Ventilated Patients - A Randomized Clinical Trial JAMA 320(20) 2087-2098. |
| Clinical Data on Daptomycin plus Ceftaroline vs standard of Care Monotherapy in the treatment of MRSA bacteremia | 06.05.2019 (Sandra Zingg) Geriak M. et al: Clinical Data on Daptomycin plus Ceftaroline vs standard of Care Monotherapy in the treatment of MRSA bacteremia Antimicrob Agents Chemother 63 E02483-18 2019 |
| Hardwiring diagnostic stewardship using electronic ordering restrictions for gastrointesetinal pathogen testing | 29.04.2019 (Andrea Büchler) Marcelin JR et al.: Hardwiring diagnostic stewardship using electronic ordering restrictions for gastrointesetinal pathogen testing Infection Control & Hospital Epidemiology 1-6 2019 |
| An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised tria | 08.04.2019 (Matthias von Rotz) Mitchell BG. et al. An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial Lancet Infect Dis 19: 410-18 2019 |
| Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial | 01.04.2019 (Sabine Kuster) Kokai-Kun J. et al.: Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial Lancet Infect Dis Published Online March 15, 2019 |
| HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation |
|
| Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients | 04.03.2019 (Veronika Bättig) Satlin MJ et al.: Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients Clin Infect Dis. 67 1720-1728 2018 |
| Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy | 25.02.2019 (Elisabeth Wehrle) Bremmer D.N. et. Al.: Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy CID 68 725-30 2019 |
| Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial | 18.02.2019 (Jacopo Nicoletti) Yahav D. et al.: Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial Clin. Infect. Dis. ePub 11.12.2018 |
| Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis |
|
| Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumonia Carbapenemase-producing K. pneumoniae | 28.01.2019 (Sabine Kuster) Tumbarello M. et al: Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumonia Carbapenemase-producing K. pneumoniae CID Volume 68-3 355-64 2019 |
| A prospective study of transmission of Multidrug-Resistant Organisms (MDROs) between environmental sites and hospitalized patients – the TransFER study | 21.01.2019 (Andrea Büchler) Chen F. et al: A prospective study of transmission of Multidrug-Resistant Organisms (MDROs) between environmental sites and hospitalized patients – the TransFER study ICHE 40 47-52 2019 |
| Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial | 14.01.2019 (Niklaus Labhardt) Jung-Kyu Lee et al.: Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial Lancet Infect Dis 19 46-55 2019 |
Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis | 07.01.2019 (Matthias von Rotz) Tricco AC et al. : Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis BMJ 363:k4029 2018 |